Clinical Trial Update: Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reports the effective dose and safety of esketamine during ultrasound-guided hepatic tumor thermal ablation in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Esketamine (esketamine)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Hepatic Neoplasm, Hepatic Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING